research use only

PF-02341066 (Crizotinib) ALK/c-Met/ROS1 Inhibitor

Cat.No.S1068

Crizotinib is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM in cell-based assays, respectively. It is also a potent ROS1 inhibitor with Ki value less than 0.025 nM. Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines.
Jump to

Quality Control

Batch: Purity: 99.92%
99.92

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 9 mg/mL (19.98 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about PF-02341066 (Crizotinib) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about PF-02341066 (Crizotinib) working concentrations for cell culture treatment

×

Mechanism of Action

Information PF-02341066 (Crizotinib) is a potent, multi-target ATP-competitive ALK, MET, and ROS1 inhibitor. It blocks ALK/MET/ROS1 and downstream AKT/ERK/STAT3 signaling by binding to the kinase ATP-binding sites, effectively inhibiting tumor cell proliferation, migration, and inducing apoptosis.

Read more about PF-02341066 (Crizotinib) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about PF-02341066 (Crizotinib) Mechanism of Action Clinical Trials

Chemical Information, Storage & Stability

Molecular Weight 450.34 Formula

C21H22Cl2FN5O

Storage (From the date of receipt)
CAS No. 877399-52-5 Download SDF Storage of Stock Solutions

Synonyms PF-02341066 SMILES CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N

Read more about storage stability stock solution CAS number SMILES

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about PF-02341066 (Crizotinib)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
Could you tell me whether this compound represents the pure R-form, or is it the racemic mixture, so a combination of the S- and the R-form?

Answer:
Our S1068 is the R enantiomer (except batches 05 and 06, which are the racemate), and S7505 is the S enantiomer.